… myocardial infarction. From literature we conclude that galectin-3 is an active player in
cardiac remodeling after myocardial infarction. Future studies should focus on the dynamics of …

… Aim: This study investigated the impact of the circulating galectin-3 level on the 30-day
prognostic outcome in patients with ST-segment elevation myocardial infarction (STEMI) …

… Gal-3 is closely associated with acute myocardial infarction (… well as prognosis prediction in
AMI patients, but controversy still … Gal-3 and unstable plaques, the secretion kinetics of Gal-3 …

… (LVEF) was significant in 505 AMI patients (Fisher′s Z −0.22, 95… galectin-3 and infarct size
was not significant in 119 patients (Fisher′s Z 0.12, 95% CI: −0.36, 0.60). Higher galectin-3 …

… , sex, comorbidities, and troponin, patients with Gal-3 values in tertiles 2 and 3 had a 1.3-fold
(… with patients with Gal-3 values in tertile 1. Patients with Gal-3 values in tertiles 2 and 3 had …

… galectin-3 in LV remodeling after AMI. We measured galectin-3 on plasma samples from a
cohort of patients … the relationships over time of plasma galectin-3 and cardiac structural and …

… involvement of galectin-3 in premature myocardial infarction. … galectin-3 we observed 1 year
after the myocardial infarction. Interestingly, Gal-3 levels were significantly higher in patients …

… galectin-3 in AMI patients with or without AF. We found that patients with AF had significantly
higher levels of galectin-3 … Patients with galectin-3 >7.57 ng/mL had 4.4 times higher odds of …

… This study evaluated the short and long-term prognostic value of galectin-3 in patients with
… Based on our results, galectin-3 might prove to be useful as a prognostic marker in patients …

… of the combined assessment of Galectin 3 (Gal-3) and Galectin 3 binding protein (Gal-3bp)
for post-AMI risk stratification in a large, consecutive population of AMI patients. The primary …